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Immunosensing using 
nanoparticles
Immunosensing technology is taking advantage of the lastest 
developments in materials science and inparticular from the 
nanomaterials field. Because of their unprecedented optical tunability 
as well as electrical and electrochemical qualities, we are seeing 
significant developments in the design of novel immunoassays; 
various conventional optical and electrical platforms which allow for 
future applications in several fields are being used. Properties of 
nanoparticles such as light absorption and dispersion are bringing 
interesting immunosensing alternatives. Nanoparticles are improving 
the sensitivity of existing techniques used for protein detection in 
immunoassays based on Surface Plasmon Resonance, Quartz Crystal 
Microbalance, Fluorescence spectroscopy etc. Electrochemical 
techniques are also taking advantage of electrical properties of 
nanoparticles. Redox properties of metal based nanoparticles, surface 
impedance change and conductance changes once nanoparticles are 
present as labelling tags or modifiers of transducer surfaces are 
also improving the technology. In most of the examples nanoparticle 
based biosensing systems are being offered as excellent screening and 
superior alternatives to existing conventional strategies/assays with 
interest for fields in clinical analysis, food quality, safety and security.
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Recent developments in nanotechnology are having marked effects 
on different industries ranging from electronics to biomedical 
engineering, by producing a new group of nanomaterials such as 
nanoparticles (NPs), including quantum dots (QDs), with unique 
semiconducting and light-emitting properties amongst other 
characteristics. Nanomaterials are defined as having a size regime 
of less than 100 nanometers and, more specifically, QDs range 
from 2-10 nanometers. From the material point of view, NPs 
are so small that they exhibit characteristics that are often not 
observed in the bulk materials. For example, gold nanoparticles 
(AuNPs) have unique properties such as a strong absorption in the 
UV-Vis up to the NIR region. QDs have unique properties because 
at this size they behave differently to their bulk equivalents 
and exhibit unprecedented tunability, enabling completely new 
applications in science and technology. This has required the 
continuous search for novel routes of synthesis of fabricated NPs 
from different materials such as Au, Pt, Fe, Co, CdS, Pd, Cu etc. 
Between the different applications the use of NPs for biosensing 
is showing an increased interest for several areas such as clinical 
analysis1,2, environmental monitoring3 as well as safety and security. 
NPs involvement in DNA, protein and even cell sensing systems 
have recently been the hottest topics in nanobiotechnology. Given 
the special importance of protein analysis we intend in this review 
to overview some of the major advances and milestones in the field 
of immunodetection systems based on NPs underlying the different 
approaches reported so far. Particular emphasis will be on the different 
optical4 and electrochemical5,6 detection methodologies where NPs 
are showing significant impact. In certain cases assays based upon 
nanomaterials have offered significant advantages over conventional 
diagnostic systems with regard to assay sensitivity, selectivity, and 
practicality7. 
Antibodies, modifications with nanoparticles 
and immunosensing
The structure of IgG, the most used antibody in immunosensig assays, 
has been determined by X-ray crystallography (Fig. 1a, upper part) 
which shows a Y-shape form consisting of three equal-sized portions, 
loosely connected by a flexible tether8. The antibodies are constituted 
by two heavy and two light polypeptide chains linked between them 
as shown in Fig. 1a (lower part). The C regions determine the isotype 
Fig. 1 (a) X-ray crystallographic structure of an IgG antibody (upper part); A schematic representation of IgG and a simplified scheme of the antibody’s structure 
(lower part). (b) The papain (upper part) and the the pepsin (lower part) cleavages. (c) Functionalization of a whole IgG or a Fab by a Mono-Sulfo-NHS-AuNP via 
free amino groups (upper part); monomaleimido AuNP binds the S atom after the reduction of the disulfide bond starting from the whole IgG (lower part, left) or 
from F(ab’)2 (lower part, right). (d) An activated by EDC AuNP coated with gluthatione, as spacer a rm, reacts with an IgG, also activated by EDC. (e) TEM images of 
AuNPs (left part) and AuNPs conjugated with IgG (right part). Image shows a thin white layer, called “halo” effect, surrounding the surface of the AuNPs indicating 
coating with protein. Adapted from8-10 and www.nanoprobes.com with permission.
(b)(a)
(c) (d)
(e)
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of the antibody whereas the variable regions of one heavy and one 
light chain constitute an antigen binding site (ABS). The digestion of 
antibody with papain (Fig. 1b upper part) and pepsin (Fig. 1b lower 
part) proteases produces several smaller fragments that may be used 
instead of the original antibody for immunosensing applications. 
Immunoassays are based on the interaction between the antibody 
and the antigen, in particular between the ABS and the epitope. 
In fact this interaction gives high specificity and sensitivity to the 
immunoassay. In order to functionalize the Ig, the connection of 
labels through three main groups: -NH2, -COOH and –SH have been 
performed. Fig. 1c (upper part) shows two examples of conjugation of 
mono-sulfo-NHS-AuNPs with an antibody through the amino group. 
A conjugation of monomaleimido AuNPs (Fig. 1c, lower part) with an 
antibody, through the –SH group, is also shown. The use of the thiol 
group for the functionalization is a good way to control the direction 
of the bond between the label and the antibody, and prevent the 
involvement of the ABS. Fig. 1d is an example of conjugation through 
the carboxyl group reported by Ahirwal et al.9. They connected the 
carboxi-term of the antibody with a AuNP by glutathione used as a 
spacer. The C-term region is a good point to attach the label, since it 
is far from the ABS and should allow the molecule interaction with the 
antigen. The AuNP modification with protein can even be observed by 
TEM (Fig. 1e)10.
In the following part the different immunosensing technologies 
ranging from optical (i.e. colorimetric) to electrical (i.e. voltammetry) 
techniques that involve the use of NPs will be discussed.
Colorimetric detection
AuNPs have an extraordinarily high extinction coefficient, emanating 
from the inherent plasmonic properties11. Their optical properties 
are strongly dependent on the interparticle separation distance, and 
aggregation that cause a massive shift in the extinction spectrum 
manifested as a color change of suspensions from red to purple12. 
The clearly distinguishable color shifts facilitate a very simple sensor 
Fig. 2 (a) Colorimetric assay based on aggregation of AuNPs. (i) Schematic representation of the assay and TEM images of the antibody conjugated AuNPs before 
and after the aggregation; (ii) Photograph showing colorimetric change upon addition of increasing concentrations of specific antigen; (iii) Absorption profile 
variation of AuNP/antibody due to the addition of specific protein. (b) Colorimetric assay based on dissagregation of AuNPs. AuNPs modified with a polypeptide 
designed to allow folding induced particle aggregation triggered by Zn2+ and a polypeptide-based synthetic receptor for binding of protein analytes (c) 
Enhancement of enzymatic colorimetric assay by NPs carriers. AuNPs modified with antibodies labelled with an enzymatic label -HRP- exert an amplification effect 
on the enzymatic colorimetric signal. Adapted from16,20,22 with permission.
(b)
(a)
(c)
(i) (ii)
(iii)
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readout that often can be performed by the naked eye. The use of 
controllable aggregation of AuNPs for biosensor applications was 
pioneered by Mirkin et al.13,14 using DNA hybridization to induce 
an assembly of particles modified with single-stranded DNA. Most 
nanoparticle-based colorimetric sensors are designed in such a way that 
binding of an analyte causes particle aggregation, and consequently a 
colorimetric response15. 
This sensing principle is recently used by Neely et al.16 for the 
detection of Alzhemer’s tau protein in the 1 pg/mL level using anti-tau 
antibody-coated AuNP. When anti-tau antibody-coated AuNPs are 
mixed with tau protein, a displacement in the wavelength of maximum 
absorbance of AuNPs is observed, allowing its sensitive detection 
(Fig. 2a). Interesting similar approaches have been reported for the 
detection of thrombin17 and rabbit IgG18 at 0.04 pM and 1.7 nM levels 
respectively. Glyconanoparticles have also been used as platforms of 
colorimetric assays for the detection of for example Cholera toxin19 at 
54 nM levels based on its interaction with the lactose contained in the 
glyconanoparticles.
Some recent works also approach the disaggregation of AuNPs 
due to the immunological reaction. This is the basis of the work 
reported by Aili et al.20 based on polypeptide-functionalized AuNPs. 
The polypeptide is designed to specifically bind to human carbonic 
anhydrase II (model protein) and the AuNPs aggregation is induced 
by the Zn2+ triggered dimerization. Folding of a second polypeptide 
also present on the surface of the AuNP, gives a readily detectable 
colorimetric shift that is dependent on the concentration of the target 
protein, allowing its detection at 10 nM levels (Fig. 2b).
In addition to AuNPs, other NPs such as AgNPs21 have been used in 
a minor extent, as sensing elements of colorimetric detection methods. 
Finally, it must be mentioned the use of AuNPs as carriers of enzymatic 
labels in colorimetric assays22, i.e. ELISAs, exerting an amplification 
effect of the enzymatic signal and improving the detection limits of the 
proteins (Fig. 2c).
Fluorescence detection
QDs, semiconductor nanoparticles with spectral characteristics, have 
been intensively studied as unique fluorescent markers23,24. QDs with 
different emission bands that depend on their diameters can be used 
as labels and all can be excited by a single wavelength. This detection 
mode is reported by Soman et al.25. They used QDs with different 
emission bands labelled with different antibodies. The simultaneous 
detection of angiopoietin-2 and mouse IgG model proteins is achieved 
in a simple way, with high sensitivity and selectivity (Fig. 3a). CdTe26, 
ZnO27 and CdSe@ZnS28,29 QDs are other examples where NPs have 
been used as direct fluorescent labels for the detection of proteins at 
very sensitive levels.
Another strategy for immunodetection approached over the 
last few years consists of the use of core-shell NPs formed by inert 
core nanoparticles (made of silica or polystyrene) and a shell of a 
fluorescent dye, mainly lanthanide chelates containing Europium (III). 
These modified NPs take advantage of the flexible surface modification 
of inert NPs and the narrow absorption and long tailing of the 
mentioned dyes, resulting in very sensitive immunoassays for 
prostate specific antigen30, human hepatitis B surface antigen31 and 
interleukin-632 amongst others at clinical relevant concentrations.
Finally, it can be highlighted the use of NPs associated with charge 
complementary fluorescent polymers to produce quenched complexes, 
as performed by You et al.33 (Fig. 3b).
Fig. 3 (a) Fluorimetric detection of QDs. (i) Different QDs are functionalized with polyclonal antibodies for different antigens. Antigens bridge polyclonal antibodies 
forming two body QDs agglomerates; (ii) Continued agglomeration yields microparticles capable of characterization by i.e. flow cytometry. (iii) The fluorescence of 
the agglomerates flowing through a microfluidic channel is measured at multiple wavelengths. (b) Fluorophore displacement protein sensor array. (i) Displacement 
of quenched fluorescent polymer (dark green strips, fluorescence off; light green strips, fluorescence on) by protein analyte (in blue) with concomitant restoration 
of fluorescence; (ii) Fluorescence pattern generation through differential release of fluorescent polymers from AuNPs. The wells on the microplate contain different 
nanoparticle–polymer conjugates, and the addition of protein analytes produces a fingerprint for a given protein. Adapted from25,33 with permission
(i) (ii)
(iii)
(i)
(ii)
(b)(a)
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Surface plasmon resonance based detection
Surface plasmon resonance (SPR) offers a flow-through biosensing 
technology that measures very small changes in refractive index on a 
noble metal surface when mass binds to that surface. To conduct a typical 
protein-protein binding study, one of the protein partners is immobilized 
on a thin gold film. When the target protein from solution binds to the 
immobilized protein partner, the binding will cause a refractive index 
change at the surface layer, which is detected by SPR through resonance 
angle change of the reflected light34,35. One of the most popular 
commercial SPR systems available is the BIAcore™. The sensitivity of 
these label-free SPR-based immunosensors can be greatly enhanced 
by using for example AuNPs tags through the electronic coupling 
interaction between the localized surface Plasmon (LSP) of the NPs and 
the surface plasmon wave associated with the SPR gold film for example. 
In addition, the active area of the LSP-based sensor is smaller, decreasing 
the minimum detectable number of molecules involved in the binding 
event. In this way, human IgE at 1ng/mL levels in an aptamer based 
immunosensor36 (Fig. 4a) and testosterone37 at physiologically relevant 
range have been detected between others. The sensitivity of these 
assays can be improved even more by secondary enzymatic precipitation 
produced by enzymes that can be loaded on the surface of the AuNPs38 
and by the fluorescence coming from fluorescence-labeled antibodies 
loaded on the AuNPs, giving rise to the technique called localised surface 
Plasmon Resonance Coupled Fluorescence (LSPCF), with fiber optic 
detection39,40.
In addition to their surface plasmon resonance absorption, light 
scattering (LS) is another optical property of AuNPs that is of great 
interest for biomolecular detection41,42. The light-scattering cross-
section of an AuNP with a diameter of 60 nm is 200-300 times 
stronger than that of a polystyrene bead of the same size, and 
4-5 orders of magnitude stronger than that of a strong fluorescence 
dye, e.g., fluorescein41. For these reasons, several works have been 
recently reported developing immunoassays based on either the static, 
linear, or nonlinear scattering properties of AuNPs43,44. 
Finally, it can also be highlighted the use of the surface-enhanced 
Raman scattering (SERS) microscopy as very sensitive technique for the 
detection of NPs tags in immunoassays. SERS is observed for molecules 
on or nearby the surface of metallic nanostructures that can support 
localized surface Plasmon resonances. The signal levels observed in 
SERS are several orders of magnitude higher than in conventional 
Raman scattering, providing the sensitivity required for bioanalytical 
and biomedical applications45-47.
In addition to their extensive use as labels, AuNPs have been 
directly assembled on the sensing surface, in order to enhance the 
SPR48 and SERS49 signal as a label-free detection system. Furthermore, 
the AuNPs allow a better oriented immobilization of antibodies, 
improving the sensitivity and selectivity of the immunoassay (Fig. 4b). 
Direct electrical detection
The excellent electroactivity of AuNPs and heavy metal based QDs 
(i.e. CdS, ZnS, PbS QDs) for example allows the use of both electrical 
or electrochemical techniques for their detection, reaching low limits 
of detection (LOD) and consequently detects low concentrations 
of proteins50. NPs can be directly detected due to their own redox 
properties (of the gold or heavy metals atoms constituents for 
example) or indirectly due to their electrocatalytic properties toward 
other species like silver reduction etc.
Several NPs present excellent electroactivity, making direct electrical 
detection possible, being not necessary any preliminary dissolution step 
to liberate the metal ions in solution. This direct electrical detection 
of NPs comprises solid state analysis, where the metals forming the 
NPs are electrically detected. However, this type of detection needs 
direct contact between the electrode surface and the metal, and 
excludes from detection a large portion of non-touching particles. 
This phenomenon could result in a loss of sensitivity, in contrast with 
techniques exploiting the total NP dissolution where all metal ions are 
Fig. 4 (a) SPR enhancement by NPs labels. The use of AuNPs conjugated with aptamers in a sandwich assay allows the amplification of the SPR signal of the label-
free assay. (b) SPR enhancement by NPs modifiers of the sensing surface The use of AuNPs platforms allows the oriented immobilization of antibody onto the AuNPs 
assembled SPR immunosensor chips for the further immunoreaction. Adapted from36,49 with permission.
(b)(a)
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detected. However, more rapid responses with acceptable LODs with a 
shorter analysis time and a more compact / integrated immunosensing 
assays are achieved with this direct detection.
The first work describing direct electrochemical detection of NPs 
was reported by Costa-García et al.51. Important contributions have 
since been made to direct electrochemical characterization or detection 
of metal and semiconductor NPs by our group and others, and some 
of the work has been reported regarding the voltammetric analysis of 
AuNPs and CdS QDs. In the case of the AuNPs52, the procedure involves 
absorption of AuNPs onto the electrode, followed by their electrochemical 
oxidation in a hydrochloric medium. The resulting tetrachloroaurate ions 
generated near the electrode surface are detected by differential pulse 
voltammetry. For CdS QDs53,54, the procedure is quite similar, but in 
this case the Cd (II) ions contained as defects in the CdS QDs crystalline 
structure are electrochemically reduced to Cd (0) and then immediately 
electro-oxidised to Cd (II), registering the oxidation peak. Based on these 
principles, solid-state detection of AuNPs55 (Fig. 5a) and Cds QDs56 
have been applied in immunoassays for the detection of human IgG and 
carcinoembryonic antigen respec tively at pM levels.
Indirect electrical detections
The most reported way to electrochemically detect NPs involved 
in bioassays consists in their preliminary oxidative dissolution in 
acidic mediums, followed by the detection of the metal ions by a 
sensitive powerful electroanalytical technique such as anodic stripping 
voltammetry. Very low LODs, in the order of pM, are achieved due 
to the release of a large number of metal ions from each NP and its 
effective ‘‘built-in’’ preconcentration step ensured by electrochemical 
stripping analysis. Dequaire et al.57 pioneered the application of this 
NP detection method for the quantification of IgG as model analyte 
at pg/mL levels. Since then, AuNPs as well as other NPs, such as 
CdS@ZnS QDs58,59 and CdSe@ZnS QDs60 have been used for the 
sensitive detection (always in the pM level) of proteins as prostate 
specific antigen or interleukin 1-α respectively. Furthermore, one of the 
most important advantages that offers the use of QDs as electroactive 
labels is their ability to perform multidetection by using QDs made of 
different inorganic crystals, with different electrochemical responses. 
This electrochemical coding technology has been approached 
by Liu et al.61 for t he simultaneous measurements of proteins 
(β2-microglobulin, IgG, bovine serum albumin and C-reactive protein) 
using ZnS, CdS, PbS and CuS QDs as tracers. (Fig. 5b).
It must also be mentioned that the high surface coupled with the easy 
bioconjugation, make NPs excellent carriers of other electroactive labels 
in immunoassays. The loading of NPs with other NPs (i.e. AuNPs loaded 
by CdS QDs62) (Fig . 5c) and with enzymes (i.e. AuNPs loaded by HRP63 
and S iNPs loaded by HRP64 or AP65) (Fig . 5d) so as to obtain labels with 
an enhanced signal have been reported as an interesting alternative for 
electrochemical immunosensing systems.
Another alternative to detect NPs used as labels in protein detection 
assays consists in using their catalytic properties toward reactions of other 
species. The well-known catalytic properties of the AuNPs on the silver 
chemical reduction have been extensively approached in the last years. 
Fig. 5 (a) Electrical detection of NPs. Direct electrical detection of AuNPs tags without acidic dissolving, based on a pre-oxidation and later reduction of Au(III) 
ions generated. (b) Electrochemical detection of NPs. The electrochemical stripping detection of different QDs labels after their acidic dissolution, allows the 
multiple detection of proteins. (c) NPs as carriers of other NPs. AuNPs can be used as carriers of a high number of CdS QDs, giving rise to an amplified signal in the 
further stripping detection after acidic dissolution. (d) NPs as carriers of enzymes. AuNPs can also be used as carriers of a high number of HRP enzymes, exerting an 
amplification effect in the electrochemical enzymatic signal. Adapted from56,62-64 with permission.
(b)(a)
(c) (d)
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Recently, our group has developed a very sensitive methodology based 
on the selective electroreduction of silver ions on the surface of AuNPs in 
magnetosandwich assays, achieving LODs of human IgG in the fM level66, 
and  has also exploited the catalytic properties of AuNPs on the hydrogen 
ions electroreduction in an acidic medium for the antigen-antibody 
interaction monitoring, applied for cancer cells detection67 (Fig. 6).
Silver nanoparticles (AgNPs) also exhibit catalytic activity on the 
chemical reduction of silver ions added as ‘substrate’. After that, the 
silver can be dissolved in for example an acidic medium and measured 
by anodic stripping voltammetry. This property has been exploited in 
sandwich immunoassays, for the sensitive detection of human IgG68 at 
pM levels.
Finally, in addition to the catalytic activity on metal ions reduction 
the catalysis of other electrochemical reactions is also reported. For 
example, the catalytic activity of PtNPs on the reduction of H2O2 to 
H2O69, and of the core-shell Au@Pd NPs on the O2 reduction to H2O70 
have been exploited by Polsky et al., for the detection of thrombin 
(nM levels) and cytokine TNF-α (fM levels) respectively.
Electromechanical detection: quartz crystal 
microbalances and microcantilevers
Microcantilevers and quartz crystal microbalances have emerged in 
the last few years as versatile biosensors demonstrating remarkable 
achievements such as high sensitivity and label free detection71-73 
(Fig. 7a, left part). In the case of the quartz crystal microbalance, the 
bioreaction generates a change in the mass, reordering the charges in 
the surface of the piezoelectric material and giving rise to a change 
in the resonant frequency of the microbalance. The use of NP labels 
in sandwich assays can increase both the surface stress and the mass 
of the immunocomplex, allowing the increase in sensitivity of these 
electromechanical assays.
This was the case in work reported by Lee et al.74 for the detection 
of prostate specific antigen at pg/mL levels using SiNPs as labels in a 
dynamic mode microcantilever based biosensor (Fig. 7a, right part and 
Fig. 7b). In a similar way, quartz crystal microbalance biosensors have 
been developed using AuNPs, as amplification agents for the detection 
of human IgG75 and aflatoxin B176 at clinical relevant levels.
NPs as modifiers of electrotransducing 
surfaces
The presence of NPs on the electrotransducer surface promotes the 
electron transfer, improving the electrochemical response coming 
from potentiometric and conductimetric responses. Furthermore, 
some NPs provide congenial microenvironments similar to that 
of redox proteins in a native system for retaining their bioactivity 
giving the protein molecules more freedom in orientation and 
Fig. 6 Electrocatalytic detection of AuNPs. (a) Detection based on the catalytic properties of AuNPs on the silver electroreduction in a magnetosandwich 
immunoassay (i); the further silver reoxidation (ii) gives rise to a peak current that can be related with the protein concentration (iii); the AuNPs (small black 
points) can be observed by TEM analysis around the magnetic beads used as immobilization platforms (big black sphere) (iv); the silver crystals formed after the 
silver electrodeposition (white points) can be observed by SEM analysis around the magnetic beads (v). (b) Detection of cells (i) based on the catalytic properties 
of AuNPs on the hydrogen evolution in an acidic medium (ii); the presence of AuNPs gives rise to a shift in the reduction potential of the hydrogen ions to hydrogen 
(lower voltammetric curve) (iii); the cells on the electrotransducer surface can be observed by SEM (iv). From67,68 with permission.
(b)
(a)
(i)
(ii)
(iii)
(v)
(iv)
(i) (ii)
(iii)
(iv)
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avoiding their denaturation. The introduction of NPs into the 
tranducing platform is commonly achieved by their adsorption onto 
conventional electrode surfaces in various forms including that of a 
composite.
PtNPs directly electrogenerated77, AuNPs adsorbed78, 
AuNPs integrated in composites79,80 or AuNPs immobilised on 
the electrotransducer surface through electrostatic forces on 
cationic polymeric layers81 are representative examples of these 
nanostructurated surfaces built for the detection of proteins such as 
human IgG, α-fetoprotein, prostate specific antigen and hepatitis B 
surface antigen at clinical relevant levels.
In addition to the final conductometric, potentiometric 
and voltammetric detection it is remarkable to see the use of 
nanostructured surfaces containing AuNPs82,83, ZrO2 NPs84 and 
CoFe2O4@SiO2 NPs85 for improving the performance of quartz crystal 
microbalance based immunosensors.
New trends: lateral flow and lab-on-a-chip
A lateral flow assay (LFA) is a prefabricated strip of a carrier material 
containing dry reagents that are activated by applying the fluid 
sample86. The  fluid movement is driven by capillary forces and 
controlled by the wettability and feature size of the porous or 
microstructured substrate87. When the recognition elements are 
antibodies, the test is called lateral flow immunoassay (LFIA). The 
first LFIA was the pregnancy test, which was based in the detection 
of human chorionic gonadotropin (HCG), and was introduced into the 
market in the middle of the ‘80s88. Nowadays several LFIAs to detect 
drug abuse, cardiac markers, and allergens are commercially available. 
The LFIA strip is generally divided in 4 zones: sample pad, conjugation 
pad, detection pad and absorbent pad used to wick the fluid through 
the membrane. In this way the amount of sample can be increased 
resulting in an increased sensitivity86 (see details at Fig. 8a, upper part).
Two formats can be used in a LFIA: competitive and sandwich 
format. In the competitive format the sample analyte competes with 
a labelled analyte for the antibodies on the test line89. In another type 
of competitive format an analyte-protein conjugate is sprayed at the 
test line and the labelled antibody is applied onto the conjugation 
pad. In this way if the sample contains the analyte then the labelled 
antibody cannot bind to the test line90 (Fig. 8b). The sandwich format 
can be used for analytes with more than one epitope. In this format 
the sample line is made of an antibody specific for one epitope of the 
analyte whereas the antibody conjugate with the labelled particles 
is specific for another epitope. In this way the analyte first binds the 
antibody of the conjugation pad and then the antibody of the test line. 
This format gives a signal proportional to the analyte concentration91 
(Fig. 8a, lower part).
Fig. 7 (a) Electromechanical immunosensing using microcantilevers. (i) The immunoreaction produces a change in the laser reflectance angle on the 
microcantilever; (ii) SEM image of single microcantilever with dimension of 50 mm/150 mm/1.75 mm (widt/ length/thickness) (left) and photo image 
(right) of a unit device with twelve microcantilevers (right); (iii) TEM images of SiNPs used to amplify the label-free immunoassay. (b) Electromechanical 
detection enhancement by NPs. The sandwich assay using polyclonal antibody conjugated SiNPs allows the enhancement of the resonant frequency shift of the 
microcantilever described in (a-ii). Adapted from74,75 with permission.
(b)
(a)
(i)
(ii)
(iii)
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The detection methods are mainly colorimetric and give results mostly 
qualitative or semi quantitative, even if, in the last year, fluorescent and 
electrochemical detection produce some quantitative results using a 
readout device92,93. The responses usually come within 2 and 15 minutes. 
The highest optical detection limit obtained with a sandwich format LFIA 
is about 1 pg/mL94, whereas the electrochemical detection limit is about 
10 pg/mL. The LFIA strips already have an important market presence due 
to their ease of use, low cost, at the point of care and fast. These qualities 
make them suitable for the home care and in vitro diagnostics. However, 
their applications in more complex samples are facing problems related to 
reproducibility and long-term operation. 
Currently, the trend in the development of biosensing systems 
is towards the miniaturization of the whole analytical chain, from 
sampling to the detection of the analytes. The advantages of 
miniaturized systems in general and particularly of microfluidic based 
biosensors are for reducing the amount of sample and reagents, 
detection facility, minimal handling of hazardous materials and 
multiple and parallel sample detection capability. Techniques such as 
fluorescence, absorbance and electrochemistry have been used for 
the final detection of the immunoassay. The combination of these 
microfluidics chips with the use of NPs, gives rise to systems with 
improvemed performance for immunosensing.
With regard to the electrochemical detection, PDMS–glass 
hybrid electro-immunosensing chips have recently been reported 
by Lee’s group95,96 for the multiplex detection of cancer biomarkers 
(α-phetoprotein, carcinoembryonic antigen and prostate specific antigen) 
at pM levels, using microbeads as antibody immobilization platforms and 
measuring the electrical resistance between microelectrodes and taking 
advantage of AuNPs labels and silver enhancement (Fig. 9a). In addition 
to the lower volumes of sample needed, the overall assay time were 
demonstrated to be reduced from 3–8 hours to about 55 minutes when 
compared to conventional immunoassays.
Alternatively, the multiplex detection of cancer biomarkers at 
clinical relevant levels has also been performed approaching the 
fluorescence properties of CdSe@ZnS in an anisotropically etched 
silicon chip97 (Fig. 9b). 
Fig. 8 Lateral flow immunoassay using NPs. (a) Schematic of a lateral flow strip (upper part) and lateral flow immunoassay (LFIA) based on a sandwich format 
(lower part).(b) Example of results obtained for a competitive LFIA. When increasing the concentration of the analyte, the intensity of test line decreases as 
expected. Adapted from88,91 with permission.
(b)(a)
Instrument Citation
Colorimetric detection
- Cary 500 scan UV-vis-NIR spectrophotometer (Varian, USA)
- Lamda 800 UV–vis spectrometer (Pekin-Elmer, USA).
- Schimadzu UV-1601PC spectrophotometer plate reader (Tecan Trading 
AG, Switzerland).
- Cary 500 scan UV-vis-NIR spectrophotometer (Varian, USA).
Fluorescence detection
- BioTek Synergy HT microplate reader (BioTek, USA).
- Nanodrop ND-3300 fluorospectrometer (Thermo Scientific, USA).
- RF-5301 PC fluorospectrometer (Shimadzu Scientific Instruments, USA)
- SPECTRAmax M2e multi-mode microplate reader (Molecular Devices Inc, USA)
- Olympus IX 71 fluorescence inverted microscope (Olympus GmbH, Germany)
Surface plasmon resonance based detection
- Autolab SPR systems (Eco Chemie, The Netherlands).
- BIAcore 2000TM (BIAcoreTM, USA).
Electrical detection
- Potentiostat / Galvanostat Autolab 12 (Eco-chemie, The Netherlands)
- Potentiostat / Galvanostat Model 600D series (CH Instruments Inc, USA).
Electromechanical detection
- EQCM cell system (CH Instruments, USA).
- Quartz crystal analyzer QCA922 (Seiko EG&G Co. Ltd. Japan).
Other characterizations of nanoparticles
- Dynamic light scattering (Zetasizer Nano ZS (Malvern Instruments , U.K.))
- Flow cytometry (BD FACSAria flow cytometer (Beckton Dickinson, USA)
- Scanning Electron Microscope (SEM) (Jeol JSM-6300, Jeol Ltd, Tokio, Japan)
- Transmission Electron Microscope (TEM) 
 Jeol JEM-2011, Jeol Ltd, Japan
H800, Hitachi, Japan
Philips CM20, Philips, The Netherlands
MT137-8p24_35.indd   32 6/24/2010   2:54:19 PM
Immunosensing using nanoparticles   REVIEW 
JULY-AUGUST 2010  |  VOLUME 13  |  NUMBER 7-8 33
Conclusions and outlook
This is a brief overview of a rapidly increasing research field in 
immunosensing using nanoparticles. The research and applications in 
this field are at the crossroads of materials research, nanosciences, 
and molecular biotechnology. Since the nanoparticles and 
biomolecules typically meet at the same nanometer length scale, this 
interdisciplinary approach will contribute to the establishment of a 
novel field, descriptively termed immunosensing nanotechnology or 
nanoimmunosensing. 
Future development of immunosensing technology will continually 
profit from the rapid current advances in material science and 
particularly that of nanomaterials science thus producing novel 
nanoparticles with improved physical and chemical properties. In 
addition, the current proteome research will also benefit since it 
provides data that allows the production of even more relevant 
bioreceptors crucial for this technology. These developments will 
open the door to more effective nanoimmunosensors with a focus on 
biomedical applications. 
In addition to the long term perspectives, today’s advanced 
nanomaterials as well as the modern optical and electrochemical 
techniques originally developed for materials research, physics and biology 
are already being used in immunosensing applications or as model systems 
with an interest in basic research as well as to solve biological and clinical 
analysis problems. NP based immunosensing systems are proving to assist 
in the development of new and versatile protein detection methods. In 
most of the reported applications NPs are seen as immunoassay labels 
achieving higher sensitivities as well and multiplexing analysis. They are also 
used as modifiers of the electrochemical or optical tranducing platforms. 
Clearly, we are still far from the real nanosensors that can operate in 
an automatic mode in living organisms. However the progress in nano 
and microsystem technology including nanomotors may open the way to 
real nanosize sensors and even to a new class of immunosensors that in 
Fig. 9 (a) Electrochemical detection in a microfluidic chips using AuNPs labels. Illustration of the electrical immunoassay. (i) A sandwich immunoassay is carried 
out in a PDMS-glass chip, using magnetic beads as platforms and AuNPs labels and the final detection is performed by measuring the electrical resistance between 
microelectrodes, taking advantage of the silver enhancement catalyzed by AuNPs. (ii) 3-D drawing of the design of the PDMS-glass electro-immunosensing chip 
(the detection zone in the chip is indicated as “D”) and photograph of the fabricated chip. (b) Fluorescent detection in a microfluidic chip using QDs labels. (i) SEM 
photomicrograph of beads in anisotropically etched silicon chip. (ii) PMMA chip layers  fabrication; (iii) Sealed LOC assembly; (iv) Fluorescent image of beads after 
immunoassay including negative controls as imaged with one second of CCD camera integration (exposure) time. Adapted from96-98 with permission. 
(b)
(a)
(i) (ii)
(i) (ii) (iii) (iv)
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an intelligent way could combine diagnostic and therapy in the so called 
theranostic98 devices. This can probably significantly shorten the time from 
protein sensing (diagnostic) to therapy (i.e. cancer cell fighting) that would 
improve an individuals life and ensure a better safety and security.  
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